Literature DB >> 12614687

Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats.

R E See1, J McLaughlin, R A Fuchs.   

Abstract

Recent evidence has demonstrated a critical role for the basolateral amygdala complex in the reinstatement of extinguished drug-seeking behavior produced by drug-paired cues. In the current study, we utilized a model of the acquisition and expression of cocaine-stimulus associative pairing in order to study the role of cholinergic input to the basolateral amygdala in mediating conditioned-cued reinstatement. Male, Sprague-Dawley rats were first trained daily to self-administer i.v. cocaine on a fixed ratio 1 schedule of reinforcement. The muscarinic acetylcholine receptor antagonist, scopolamine, was directly infused into the basolateral amygdala prior to: a) classically conditioned pairing of a tone+light stimulus with cocaine infusions (acquisition), or b) testing of conditioned-cued reinstatement following a period of withdrawal from cocaine and extinction of cocaine-paired lever responding. Infusion of scopolamine just prior to the classical conditioning trial produced a dose-dependent disruption of cocaine-seeking behavior maintained by cocaine-paired cues during the reinstatement test. In contrast, infusion of scopolamine prior to the reinstatement test had no effect on conditioned-cued reinstatement of cocaine-seeking behavior. These results indicate a crucial role for cholinergic innervation of muscarinic acetylcholine receptors in the basolateral amygdala during the formation, but not the expression, of stimulus-reward associations that mediate cue-induced cocaine-seeking behavior.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614687     DOI: 10.1016/s0306-4522(02)00665-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

Review 1.  The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.

Authors:  David H Root; Roberto I Melendez; Laszlo Zaborszky; T Celeste Napier
Journal:  Prog Neurobiol       Date:  2015-04-06       Impact factor: 11.685

2.  Effect of amphetamine place conditioning on excitatory synaptic events in the basolateral amygdala ex vivo.

Authors:  A Hetzel; G E Meredith; D J Rademacher; J A Rosenkranz
Journal:  Neuroscience       Date:  2012-01-18       Impact factor: 3.590

3.  Blockade of muscarinic acetylcholine receptors in the ventral tegmental area disrupts food-related learning in rats.

Authors:  Ruth Sharf; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

4.  Instrumental learning, but not performance, requires dopamine D1-receptor activation in the amygdala.

Authors:  M E Andrzejewski; R C Spencer; A E Kelley
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.

Authors:  Kelly A Carrigan; Linda A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

Review 6.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

7.  Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent.

Authors:  Brian A McCool; Ann Chappell
Journal:  Behav Brain Res       Date:  2007-01-17       Impact factor: 3.332

Review 8.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

Review 9.  Systems level neuroplasticity in drug addiction.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

10.  Scopolamine detoxification technique for heroin dependence: a randomized trial.

Authors:  Sheng Liu; Longhui Li; Wenwen Shen; Xueyong Shen; Guodong Yang; Wenhua Zhou
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.